Figure 4.
Figure 4. The ecdhMUC1 protein released from Ad-sig-ecdhMUC1/ecdCD40L vector-infected cells forms functional trimers and activates DCs. (A) Induction of IFN-γ secretion from bone marrow-derived DCs induced by exposure to the Ad-sig-ecdhMUC1/ecdCD40L vector. Supernatant medium collected from DCs derived in vitro from hMUC1.Tg mice after exposure to the Ad-sig-ecdhMUC1/ecdCD40L vector or to the Ad-sig-ecdhMUC1 vector and then analyzed for the levels of IFN-γ. (B) Induction of IL-12 secretion from bone marrow-derived DCs induced by exposure to the Ad-sig-ecdhMUC1/ecdCD40L or the Ad-sig-ecdhMUC1 vectors. The same procedure outlined for panel A was carried out, except that the supernatant medium was analyzed for IL-12. (C) Nondenaturing gel analysis of molecular weights of the ecdhMUC1/ecdCD40L protein. A construct was created in which a His tag was placed at the carboxyl terminal end of the CD40L, and an HSF1 trimeric stabilization domain was added between the ecdhMUC1 and ecdCD40L domains. After release from vector-infected cells, the protein was purified using a His tag column, concentrated, and added to a nondenaturing gel. The protein in the lane labeled MUC1/CD40L trimer was added to the nondenaturing gel without treatment. The protein in the lane labeled MUC1/CD40L monomer was first treated with the denaturing conditions before loading on the gel. Molecular weight markers are given in the extreme right lane.

The ecdhMUC1 protein released from Ad-sig-ecdhMUC1/ecdCD40L vector-infected cells forms functional trimers and activates DCs. (A) Induction of IFN-γ secretion from bone marrow-derived DCs induced by exposure to the Ad-sig-ecdhMUC1/ecdCD40L vector. Supernatant medium collected from DCs derived in vitro from hMUC1.Tg mice after exposure to the Ad-sig-ecdhMUC1/ecdCD40L vector or to the Ad-sig-ecdhMUC1 vector and then analyzed for the levels of IFN-γ. (B) Induction of IL-12 secretion from bone marrow-derived DCs induced by exposure to the Ad-sig-ecdhMUC1/ecdCD40L or the Ad-sig-ecdhMUC1 vectors. The same procedure outlined for panel A was carried out, except that the supernatant medium was analyzed for IL-12. (C) Nondenaturing gel analysis of molecular weights of the ecdhMUC1/ecdCD40L protein. A construct was created in which a His tag was placed at the carboxyl terminal end of the CD40L, and an HSF1 trimeric stabilization domain was added between the ecdhMUC1 and ecdCD40L domains. After release from vector-infected cells, the protein was purified using a His tag column, concentrated, and added to a nondenaturing gel. The protein in the lane labeled MUC1/CD40L trimer was added to the nondenaturing gel without treatment. The protein in the lane labeled MUC1/CD40L monomer was first treated with the denaturing conditions before loading on the gel. Molecular weight markers are given in the extreme right lane.

Close Modal

or Create an Account

Close Modal
Close Modal